Not Tagged
Not Tagged
['multiple myeloma']
had the opportunity to present our work on trial enrollment disparities in newly-diagnosed multiple myeloma at #asco2023 hispanics had significantly lower odds (or 0.18!!!) of being enrolled in phase ii/iii frontline therapy trials. trial enrollment fractions were also lower 
Internal Medicine Resident @MountSinaiNYC, Myeloma & Cell therapy Enthusiast, @ASH_hematology HONORS Awardee, First-Gen Doc from Brazil. Views are my own